Figure 2.
Figure 2. Activated alloantigen-induced CD25+CD4+ cells can regulate third-party skin allograft rejection. (A) Pretreatment and adoptive transfer protocol. CBA-Rag-/- mice were reconstituted with 105 CD45RBhighCD4+ cells with or without 2 × 105 CD25+CD4+ cells from CBA mice pretreated with 200 μg YTS177 and 250 μL BALB blood followed by a further dose of BALB blood the day prior to cell isolation. The reconstituted mice then received a B10 skin graft the following day. (B) Effect of CD25+CD4+ cells on CD45RBhighCD4+-mediated rejection of B10 skin grafts. □ CD45RBhighCD4+ cells only (MST, 17 days, n = 4); ▪ CD45RBhighCD4+ plus CD25+CD4+ cells (MST, > 100 days, n = 4; P < .05). (C) Representative skin graft 100 days after transplantation onto mouse reconstituted with both CD45RBhigh CD4+ and CD25+CD4+ cells. (D) Histology of graft in panel C (H&E).

Activated alloantigen-induced CD25+CD4+ cells can regulate third-party skin allograft rejection. (A) Pretreatment and adoptive transfer protocol. CBA-Rag-/- mice were reconstituted with 105 CD45RBhighCD4+ cells with or without 2 × 105 CD25+CD4+ cells from CBA mice pretreated with 200 μg YTS177 and 250 μL BALB blood followed by a further dose of BALB blood the day prior to cell isolation. The reconstituted mice then received a B10 skin graft the following day. (B) Effect of CD25+CD4+ cells on CD45RBhighCD4+-mediated rejection of B10 skin grafts. □ CD45RBhighCD4+ cells only (MST, 17 days, n = 4); ▪ CD45RBhighCD4+ plus CD25+CD4+ cells (MST, > 100 days, n = 4; P < .05). (C) Representative skin graft 100 days after transplantation onto mouse reconstituted with both CD45RBhigh CD4+ and CD25+CD4+ cells. (D) Histology of graft in panel C (H&E).

Close Modal

or Create an Account

Close Modal
Close Modal